DK143436B - Fremgangsmaade til fremstilling af tabletter med et hoejt indhold af antiob ld af antibiotika - Google Patents

Fremgangsmaade til fremstilling af tabletter med et hoejt indhold af antiob ld af antibiotika Download PDF

Info

Publication number
DK143436B
DK143436B DK565773AA DK565773A DK143436B DK 143436 B DK143436 B DK 143436B DK 565773A A DK565773A A DK 565773AA DK 565773 A DK565773 A DK 565773A DK 143436 B DK143436 B DK 143436B
Authority
DK
Denmark
Prior art keywords
tablets
antibiotics
starch
high content
antiob
Prior art date
Application number
DK565773AA
Other languages
Danish (da)
English (en)
Inventor
H G Freuer
D Hiller
H Mueller
G Ross
W Tillmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK143436B publication Critical patent/DK143436B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK565773AA 1972-10-19 1973-10-18 Fremgangsmaade til fremstilling af tabletter med et hoejt indhold af antiob ld af antibiotika DK143436B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2251250 1972-10-19
DE2251250A DE2251250C3 (de) 1972-10-19 1972-10-19 Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten

Publications (1)

Publication Number Publication Date
DK143436B true DK143436B (da) 1981-08-24

Family

ID=5859487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK565773AA DK143436B (da) 1972-10-19 1973-10-18 Fremgangsmaade til fremstilling af tabletter med et hoejt indhold af antiob ld af antibiotika

Country Status (10)

Country Link
AT (1) AT338430B (de)
BE (1) BE806294A (de)
CH (1) CH608964A5 (de)
DE (1) DE2251250C3 (de)
DK (1) DK143436B (de)
FR (1) FR2247208B1 (de)
GB (1) GB1451804A (de)
NL (1) NL7314085A (de)
SE (1) SE416176B (de)
ZA (1) ZA738100B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034035A (en) * 1975-07-14 1977-07-05 Merck & Co., Inc. Method of preparing multi-toned tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
ZA961018B (en) * 1995-02-08 1997-08-08 Yamanouchi Europ Bv Oral dosage-forms containing a beta-lactam antibiotic.
EA001089B1 (ru) * 1996-02-29 2000-10-30 Фудзисава Фармасьютикал Ко., Лтд. ТАБЛЕТКИ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК, И СПОСОБ ИХ ИЗГОТОВЛЕНИЯ
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
WO1998034598A2 (en) * 1997-02-07 1998-08-13 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
TR200000529T2 (tr) * 1997-08-29 2000-08-21 Dsm N.V. İçinde eksipiyan olmayan granüller
AU1337999A (en) * 1997-11-17 1999-06-07 Gist-Brocades B.V. Granules comprising clavulanate and one or more excipients
CN114939113A (zh) * 2022-06-01 2022-08-26 澳美制药(苏州)有限公司 青霉素v钾片及其制备方法

Also Published As

Publication number Publication date
SE416176B (sv) 1980-12-08
DE2251250C3 (de) 1981-06-25
FR2247208A1 (de) 1975-05-09
DE2251250B2 (de) 1979-10-04
GB1451804A (en) 1976-10-06
AU6151373A (en) 1975-04-17
DE2251250A1 (de) 1974-05-02
CH608964A5 (en) 1979-02-15
FR2247208B1 (de) 1978-11-03
AT338430B (de) 1977-08-25
NL7314085A (de) 1974-04-23
ZA738100B (en) 1975-05-28
ATA884973A (de) 1976-12-15
BE806294A (fr) 1974-04-19

Similar Documents

Publication Publication Date Title
US4587118A (en) Dry sustained release theophylline oral formulation
DK175508B1 (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmåder til fremstilling af henholdsvis denne tablet og dette granulat
EP0129382B1 (de) Lang wirksame Cefaclor-Formulierung und deren Herstellung
US5211958A (en) Pharmaceutical composition and process for its preparation
DK175620B1 (da) Farmaceutisk matrix-formulering i tabletform med forsinket frigivelse af den aktive bestanddel
DK144306B (da) Grundmasse til anvendelse ved fremstilling af en farmaceutisk enhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf
US4301176A (en) Method of administering calcium valproate
KR101370712B1 (ko) 복합 조성물
DK158540B (da) Orale, ikke-retarderede dipyridamolformer og fremgangsmaade til deres fremstilling
DK161014B (da) Fremgangsmaade til fremstilling af terapeutiske praeparater med forsinket frigivelse paa basis af hydroxypropylmethylcellulose med hoej molekylvaegt
BG61677B1 (bg) Лекарствена форма за орално приложение за лечение назаболявания, свързани с липсата на допамин
DK143436B (da) Fremgangsmaade til fremstilling af tabletter med et hoejt indhold af antiob ld af antibiotika
US2656298A (en) Therapeutic product
NO309455B1 (no) Filmbelagt tablett av paracetamol og domperidon
KR100263284B1 (ko) 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하는 생체 이용률이 개선된 정제
IE912885A1 (en) Multiparticulate sustained release matrix system
US2798024A (en) Composite enteric tablet of erythromycin and sulfonamides
US3018221A (en) Penicillin-sulfonamide tablet
US3931404A (en) High dosage orally administrable cephalosporin antibiotic preparations
WO1993017679A1 (en) Compositions containing ranitidine/bismuth carboxylates salts
KR20160002177A (ko) 오셀타미비어 유리염기를 포함하는 약학 조성물
DK175526B1 (da) Farmaceutisk præparat og fremgangsmåde til dets fremstilling
KR20230086370A (ko) 다파글리플로진과 피오글리타존을 포함하는 약제학적 복합제제 및 이의 제조방법
US2866735A (en) Therapeutic composition of matter
JP4370050B2 (ja) クラリスロマイシン錠剤およびその製造法

Legal Events

Date Code Title Description
PTS Application withdrawn